$CVRX
CVRx, Inc.

2024 Q1 Form 10-K Financial Statement

#000155837024000932 Filed on February 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $10.77M $11.31M $39.30M
YoY Change 34.98% 57.54% 74.89%
Cost Of Revenue $1.615M $1.720M $6.256M
YoY Change 21.61% 13.98% 25.15%
Gross Profit $9.155M $9.585M $33.04M
YoY Change 37.65% 69.14% 89.12%
Gross Profit Margin 85.0% 84.79% 84.08%
Selling, General & Admin $28.33M $17.01M $64.51M
YoY Change 84.0% 20.6% 28.9%
% of Gross Profit 309.45% 177.41% 195.25%
Research & Development $3.057M $2.241M $11.63M
YoY Change -10.51% -26.43% 16.89%
% of Gross Profit 33.39% 23.38% 35.21%
Depreciation & Amortization $131.0K $132.0K $500.0K
YoY Change 1.55% 3.13% 25.0%
% of Gross Profit 1.43% 1.38% 1.51%
Operating Expenses $31.39M $19.25M $76.14M
YoY Change 66.84% 12.25% 26.91%
Operating Profit -$22.23M -$9.661M -$43.10M
YoY Change 82.8% -15.84% 1.35%
Interest Expense -$960.0K -$579.0K -$1.799M
YoY Change -500.0% 250.91% 990.3%
% of Operating Profit
Other Income/Expense, Net $1.044M $1.116M $3.850M
YoY Change -1.69% -1.76% 180.41%
Pretax Income -$22.15M -$9.124M -$41.05M
YoY Change 95.31% -13.17% -0.65%
Income Tax $38.00K $39.00K $147.0K
% Of Pretax Income
Net Earnings -$22.19M -$9.163M -$41.20M
YoY Change 95.06% -13.03% -0.55%
Net Earnings / Revenue -206.0% -81.05% -104.85%
Basic Earnings Per Share -$1.04 -$1.99
Diluted Earnings Per Share -$1.05 -$0.44 -$1.99
COMMON SHARES
Basic Shares Outstanding 20.93M 20.82M 20.75M
Diluted Shares Outstanding 21.23M 20.75M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.12M $90.57M $90.57M
YoY Change -22.43% -14.71% -14.71%
Cash & Equivalents $80.12M $90.57M $90.57M
Short-Term Investments
Other Short-Term Assets $2.656M $2.987M $2.987M
YoY Change 0.95% -29.27% -29.27%
Inventory $11.06M $10.98M $10.98M
Prepaid Expenses
Receivables $8.495M $7.551M $7.551M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $102.3M $112.1M $112.1M
YoY Change -15.14% -8.78% -8.78%
LONG-TERM ASSETS
Property, Plant & Equipment $3.823M $3.112M $3.112M
YoY Change 111.8% 53.15% 53.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.00K $27.00K $27.00K
YoY Change -3.7% 0.0% 0.0%
Total Long-Term Assets $3.849M $3.139M $3.139M
YoY Change 82.5% 52.45% 52.45%
TOTAL ASSETS
Total Short-Term Assets $102.3M $112.1M $112.1M
Total Long-Term Assets $3.849M $3.139M $3.139M
Total Assets $106.2M $115.2M $115.2M
YoY Change -13.46% -7.77% -7.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.608M $1.884M $1.884M
YoY Change 30.66% 9.6% 9.6%
Accrued Expenses $5.790M $5.980M $5.980M
YoY Change -2.87% -6.11% -6.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.398M $7.864M $7.864M
YoY Change 5.54% -2.77% -2.77%
LONG-TERM LIABILITIES
Long-Term Debt $29.27M $29.22M $29.22M
YoY Change 105.87% 333.11% 333.11%
Other Long-Term Liabilities $2.242M $2.196M $2.196M
YoY Change 175.09% 138.18% 138.18%
Total Long-Term Liabilities $31.51M $31.42M $31.42M
YoY Change 109.62% 309.68% 309.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.398M $7.864M $7.864M
Total Long-Term Liabilities $31.51M $31.42M $31.42M
Total Liabilities $39.91M $39.28M $39.28M
YoY Change 73.15% 149.3% 149.3%
SHAREHOLDERS EQUITY
Retained Earnings -$499.6M -$477.4M
YoY Change 11.62% 9.45%
Common Stock $566.0M $553.5M
YoY Change 3.4% 1.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.26M $75.95M $75.95M
YoY Change
Total Liabilities & Shareholders Equity $106.2M $115.2M $115.2M
YoY Change -13.46% -7.77% -7.77%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$22.19M -$9.163M -$41.20M
YoY Change 95.06% -13.03% -0.55%
Depreciation, Depletion And Amortization $131.0K $132.0K $500.0K
YoY Change 1.55% 3.13% 25.0%
Cash From Operating Activities -$10.90M -$7.841M -$39.02M
YoY Change 6.31% -27.67% -8.57%
INVESTING ACTIVITIES
Capital Expenditures $917.0K $171.0K $591.0K
YoY Change 282.08% 116.46% -13.72%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$917.0K -$171.0K -$591.0K
YoY Change 282.08% 116.46% -13.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.362M 15.58M 23.98M
YoY Change -82.0% 118.97% 220.09%
NET CHANGE
Cash From Operating Activities -10.90M -7.841M -39.02M
Cash From Investing Activities -917.0K -171.0K -591.0K
Cash From Financing Activities 1.362M 15.58M 23.98M
Net Change In Cash -10.45M 7.572M -15.63M
YoY Change 258.26% -299.11% -56.45%
FREE CASH FLOW
Cash From Operating Activities -$10.90M -$7.841M -$39.02M
Capital Expenditures $917.0K $171.0K $591.0K
Free Cash Flow -$11.81M -$8.012M -$39.61M
YoY Change 12.62% -26.63% -8.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.99
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.02
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20754375
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20532838
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20754375
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20532838
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.99
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.02
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001235912
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20879199
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20663736
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40545
CY2023 dei Entity Registrant Name
EntityRegistrantName
CVRx, Inc
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1983744
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6369000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7864000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8088000
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
9201 West Broadway Avenue
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55445
CY2023 dei City Area Code
CityAreaCode
763
CY2023 dei Local Phone Number
LocalPhoneNumber
416-2840
CY2023 dei Security12b Title
Security12bTitle
Common stock,
CY2023 dei Trading Symbol
TradingSymbol
CVRX
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
190000000.0
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20927729
CY2023 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2023 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90569000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106194000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
508000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
679000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7551000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5504000
CY2023Q4 us-gaap Inventory Net
InventoryNet
10983000
CY2022Q4 us-gaap Inventory Net
InventoryNet
6957000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2987000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4223000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
112090000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
122878000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1763000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1698000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1349000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
334000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27000
CY2023Q4 us-gaap Assets
Assets
115229000
CY2022Q4 us-gaap Assets
Assets
124937000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1884000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1719000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5980000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29222000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6747000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1160000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
117000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1036000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
805000
CY2023Q4 us-gaap Liabilities
Liabilities
39282000
CY2022Q4 us-gaap Liabilities
Liabilities
15757000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20879199
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20663736
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
209000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
207000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
553326000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
545362000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-477381000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-436182000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-207000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-207000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
75947000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
109180000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115229000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
124937000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39295000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22469000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
6256000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
4999000
CY2023 us-gaap Gross Profit
GrossProfit
33039000
CY2022 us-gaap Gross Profit
GrossProfit
17470000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11633000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9952000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64509000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
50045000
CY2023 us-gaap Operating Expenses
OperatingExpenses
76142000
CY2022 us-gaap Operating Expenses
OperatingExpenses
59997000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-43103000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-42527000
CY2023 us-gaap Interest Expense
InterestExpense
1799000
CY2022 us-gaap Interest Expense
InterestExpense
165000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3850000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1373000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-41052000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-41319000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
147000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-41199000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-41428000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-9000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41199000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41437000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.99
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.02
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20754375
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20532838
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
145959000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
184000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
587000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3887000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-41428000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
109180000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
728000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
935000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6303000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-41199000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
75947000
CY2023 us-gaap Profit Loss
ProfitLoss
-41199000
CY2022 us-gaap Profit Loss
ProfitLoss
-41428000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6303000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3887000
CY2023 us-gaap Depreciation
Depreciation
522000
CY2022 us-gaap Depreciation
Depreciation
412000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
154000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
25000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2047000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2944000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4026000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3077000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1273000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1634000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
165000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1209000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-170000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
873000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39021000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42677000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
591000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
685000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-591000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-685000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
728000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
184000
CY2023 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
935000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
587000
CY2023 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
22500000
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
7500000
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
179000
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
778000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23984000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7493000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15625000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35878000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106194000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142072000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90569000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106194000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1396000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
59000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
4000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
5000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.</p>
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4714000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2390000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
654000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1033000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5615000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3534000
CY2023Q4 us-gaap Inventory Net
InventoryNet
10983000
CY2022Q4 us-gaap Inventory Net
InventoryNet
6957000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4551000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3978000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2788000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2280000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1763000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1698000
CY2023 us-gaap Depreciation
Depreciation
500000
CY2022 us-gaap Depreciation
Depreciation
400000
CY2023Q4 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
277000
CY2022Q4 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1733000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
3335000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2303000
CY2023Q4 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
770000
CY2022Q4 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
960000
CY2023Q4 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
411000
CY2022Q4 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
256000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
231000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
222000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
125000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
120000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
831000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
775000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5980000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6369000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
20000000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
10000000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
778000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29222000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1349000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
231000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1160000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1391000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
315000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
350000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
362000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
374000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
223000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1624000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
233000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1391000
CY2023Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P4Y8M12D
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.067
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
400000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
400000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.95
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y6M
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6303000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3887000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6303000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3887000
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
13400000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
147000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
109000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
147000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 cvrx Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
-0.043
CY2022 cvrx Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
-0.021
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.014
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.008
CY2023 cvrx Effective Income Tax Rate Reconciliation Uncertain Tax Position Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercent
-0.003
CY2022 cvrx Effective Income Tax Rate Reconciliation Uncertain Tax Position Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercent
-0.003
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.026
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.005
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.004
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.003
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.212
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.195
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.004
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.003
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
89173000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
82050000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9664000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9072000
CY2023Q4 cvrx Deferred Tax Assets Capitalized Research And Development Expenses
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses
8963000
CY2022Q4 cvrx Deferred Tax Assets Capitalized Research And Development Expenses
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses
8412000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1473000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
752000
CY2023Q4 cvrx Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
680000
CY2022Q4 cvrx Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
894000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
179000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
212000
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
59000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
144000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
361000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
300000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
110552000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
101836000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
110552000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
101836000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2046000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1939000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
12000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
4000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
185000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
113000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
22000
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
10000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2221000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2046000
CY2023 cvrx Unrecognized Tax Benefits Subjected To Valuation Allowance
UnrecognizedTaxBenefitsSubjectedToValuationAllowance
1700000
CY2022 cvrx Unrecognized Tax Benefits Subjected To Valuation Allowance
UnrecognizedTaxBenefitsSubjectedToValuationAllowance
1600000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
100000
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
500000
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
400000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-41199000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-41428000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20754375
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20532838
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.99
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.02
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5204976
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4472966
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
0
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
0
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39295000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22469000
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
248

Files In Submission

Name View Source Status
0001558370-24-000932-index-headers.html Edgar Link pending
0001558370-24-000932-index.html Edgar Link pending
0001558370-24-000932.txt Edgar Link pending
0001558370-24-000932-xbrl.zip Edgar Link pending
cvrx-20231231.xsd Edgar Link pending
cvrx-20231231x10k.htm Edgar Link pending
cvrx-20231231x10k006.jpg Edgar Link pending
cvrx-20231231x10k007.jpg Edgar Link pending
cvrx-20231231x10k008.jpg Edgar Link pending
cvrx-20231231x10k009.jpg Edgar Link pending
cvrx-20231231x10k010.jpg Edgar Link pending
cvrx-20231231x10k011.jpg Edgar Link pending
cvrx-20231231x10k012.jpg Edgar Link pending
cvrx-20231231x10k013.jpg Edgar Link pending
cvrx-20231231x10k014.jpg Edgar Link pending
cvrx-20231231x10k015.jpg Edgar Link pending
cvrx-20231231x10k016.jpg Edgar Link pending
cvrx-20231231x10k017.jpg Edgar Link pending
cvrx-20231231xex10d7.htm Edgar Link pending
cvrx-20231231xex10d7001.jpg Edgar Link pending
cvrx-20231231xex23d1.htm Edgar Link pending
cvrx-20231231xex31d1.htm Edgar Link pending
cvrx-20231231xex31d2.htm Edgar Link pending
cvrx-20231231xex32d1.htm Edgar Link pending
cvrx-20231231xex32d2.htm Edgar Link pending
cvrx-20231231xex97d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
cvrx-20231231_def.xml Edgar Link unprocessable
cvrx-20231231_lab.xml Edgar Link unprocessable
cvrx-20231231_pre.xml Edgar Link unprocessable
cvrx-20231231x10k_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cvrx-20231231_cal.xml Edgar Link unprocessable